Speaker illustration

Doctor Jonathan Hinton

University Dorset Hospital, Bournemouth (United Kingdom of Great Britain & Northern Ireland)

High-sensitivity troponin is a biomarker of medium term mortality in 20,000 consecutive hospital patients undergoing a blood test for any reason

Event: ESC Congress 2022

Topic: Biomarkers

Session: Troponin and other biomarkers in acute coronary syndromes

Thumbnail

The relationship between high-sensitivity troponin taken on admission to critical care, regardless of whether there was a clinical indication for testing, and one year mortality

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Thumbnail

Incidence and one year outcome of periprocedural myocardial infarction following cardiac surgery: are the universal definition and SCAI criteria fit for purpose?

Event: ESC Congress 2021 - The Digital Experience

Topic: Revascularisation

Session: Acute Coronary Syndromes ePosters

Thumbnail

Distribution of high sensitivity troponin taken without conventional clinical indications in critical care patients and its association with mortality

Event: ESC Congress 2020

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb